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Abstract 
Superoxide anion generation plays an important role in the development of paraquat 
toxicity. Although superoxide dismutase mimetics (SODm) have provided protection 
against organ injury involving generation of superoxide anions, they often suffer 
problems, e.g., regarding their bioavailability or potential pro-oxidant activity. The 
aim here was to investigate and compare the therapeutic potential of two novel 
SODm, manganese(II) and copper(II) complexes of the calcium chelator 
ethylenebis(oxyethylenenitrilo)tetraacetic acid (EGTA) and of the contrast agent 
ethylenebis(hydroxyphenylglycine) (EHPG), against paraquat-induced renal toxicity 
in vitro. Incubation of renal NRK-52E cells with paraquat (1 mM) for 24 h produced 
submaximal, yet significant, reduction in cellular viability and cell death and 
produced significant increases in superoxide anion and hydroxyl radical generation. 
Manganese and copper complexes of EGTA (10–100 μM) and EHPG (30–100 μM) 
reduced paraquat-induced renal cell toxicity and reduced superoxide anion and 
hydroxyl radical generation significantly. Manganese complexes displayed greater 
efficacy than copper complexes and, at equivalent concentrations, manganese 
complexed with EHPG provided the greatest protection. Furthermore, these metal 
complexes did not interfere with the uptake of [methyl-14C]paraquat into NRK-52E 
cells, suggesting that they provided protection against paraquat cytotoxicity via 
intracellular mechanisms. These complexes did not display cytotoxicity at the 
concentrations examined. Together, these results suggest that manganese and copper 
complexes of EGTA and EHPG, and especially the manganese–EHPG complex, 
could provide benefit against paraquat nephrotoxicity. 
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Introduction 
Paraquat (1,1′-dimethyl-4,4′-bipyridium dichloride, also known as methyl viologen) is 
a widely used broad-spectrum and fast-acting herbicide. However, it is extremely 
toxic, causing fatalities due to accidental or intentional poisoning, prevalently in 
developing countries [1] and [2]. Paraquat poisoning causes severe multiple organ 
failure, with the degree of poisoning dependent on the route of administration, the 
amount administered, and the duration of exposure. It is rapidly distributed within the 
body with highest concentrations accumulating within the kidneys, where it produces 
early and severe nephrotoxicity [3]. Additionally, as it is primarily excreted 
unchanged via the kidneys, the consequent reduction in renal function increases 
plasma concentrations by up to fivefold, which contributes to paraquat toxicity in 
other organs, especially the lungs [4] and [5]. Ultimately, respiratory failure, in the 
presence of nephrotoxic acute renal failure, is responsible for most deaths caused by 
paraquat [5], [6] and [7]. Therefore, maintaining renal function in patients suffering 
from paraquat poisoning remains a therapeutically important treatment strategy. 
Generation of reactive oxygen species (ROS), such as superoxide anions, plays a 
major part in the development of paraquat-induced toxicity [8] and [9] and especially 
nephrotoxicity [10] and [11].Current research has therefore focused on the therapeutic 
potential of antioxidants against paraquat-induced toxicity, especially those that can 
degrade superoxide anions such as superoxide dismutase (SOD) [12]. Unfortunately, 
the effectiveness of exogenously administered antioxidant enzymes such as SOD in 
vivo has been hindered by factors such as its poor bioavailability, low stability, or 
rapid hydrolysis in the blood and problems regarding its immunogenicity [13], 
[14] and [15]. Furthermore, SOD itself can have pro-oxidant effects at higher 
concentrations [16], [17], [18] and [19], for example, via the possibility that Cu2+ 
derived from Cu/ZnSOD may facilitate the generation of oxidative stress in the 
presence of glutathione [17] or via the ability of superoxide to both initiate and 
terminate lipid peroxidation [19]. Subsequently, many different types of SOD 
mimetics (SODm) have been synthesized [15] and [20], including manganese(III) 
tetrakis(4-benzoic acid) porphyrin (MnTBAP) and M40401 (a manganese-containing 
SODm), which have been shown to reduce paraquat-induced lung and brain injury in 
the mouse and rat, respectively [21] and [22]. However, SODm also suffer problems 
regarding bioavailability and toxicity, e.g., their poor stability in vivo and pro-oxidant 
activities [23] and [24]. 
The calcium chelator ethylenebis(oxyethylenenitrilo) tetraacetic acid (EGTA) has 
recently been shown to possess significant SOD activity [25] and has provided 
benefits in models of multiple sclerosis and Alzheimer disease [26] and [27]. Another 
chelator, ethylenebis(hydroxyphenylglycine) (EHPG), which is used as a contrast 
agent in imaging and as a transferrin mimic in the study of manganese transport 
[28] and [29], also exhibits SODm properties when complexed with manganese (Mn) 
(II) or copper (Cu) (II) [25]. A major advantage of the potential use of these agents for 
the treatment of disease is that EGTA and EHPG have already been used 
therapeutically [26], [27], [28] and [29]. Furthermore, Mn(II) and Cu(II) complexes of 
EGTA and EHPG are stable in solution and have a good safety profile in that they do 
not promote pro-oxidant activities [25]. 
To date, the protection afforded by Mn and Cu complexes of EGTA and EHPG on 
ROS generation and subsequent injury and death of renal cells has not been 
investigated. The aims of this study were to: (i) confirm the role of ROS in the 
development of paraquat-induced renal (NRK-52E) cell cytotoxicity and (ii) 
investigate and compare the therapeutic potential of EGTA and EHPG and their 
Mn(II) and Cu(II) complexes against paraquat-induced renal cytotoxicity in vitro. The 
mechanisms by which metal complexes of EGTA and EHPG could protect NRK-52E 
cells against paraquat toxicity were investigated, both by assessing the ability of these 
complexes to reduce ROS generation by paraquat and by examining the ability of the 
complexes to alter the uptake of paraquat into renal cells. 
Materials and methods 
Unless otherwise stated, all compounds used in this study were purchased from 
Sigma–Aldrich Co. Ltd. (Poole, Dorset, UK). Mn(II) and Cu(II) were obtained from 
Sigma–Aldrich in the form of Mn(II) sulfate and Cu(II) chloride (MnSO4 and CuCl2). 
Mn(II) and Cu(II) complexes of EGTA and EHPG were synthesized as described 
previously [25]. 
Culture of NRK-52E cells 
NRK-52E cells, which maintain characteristics of renal proximal tubular cells in 
culture [30], were obtained at passage 24 from the European Collection of Cell 
Cultures (Salisbury, Wiltshire, UK) and used between passages 28 and 60. Cells were 
routinely cultured in 80-cm2 Nunc flasks (Fisher Scientific, Loughborough, 
Leicestershire, UK) and grown in Dulbecco's modified Eagle's medium (DMEM; 
Cambrex BioScience, Wokingham, Berkshire, UK), supplemented with 10% (v/v) 
fetal bovine serum (FBS; Biosera, Ringmer, East Sussex, UK), 1% nonessential 
amino acid solution, 100 U/ml penicillin, and 50 μg/ml streptomycin at 37°C in a 
humidified 5% carbon dioxide atmosphere. Culture medium was changed every 48 h. 
NRK-52E cells were subcultured at 90% confluence using a trypsin (0.1% 
w/v)/versene (0.02% w/v) mixture. For experiments, cells were subcultured and 
grown on 6- or 24-well Nunc plates (Fisher Scientific) in DMEM as described above 
except for the substitution of 5% (v/v) FBS. DMEM as described above but 
containing only 1% (v/v) FBS was used for incubations involving paraquat, metal 
complexes of EGTA and EHPG, or their individual components. 
Measurement of paraquat toxicity 
Confluent cultures of NRK-52E cells on 24-well plates were incubated for 24 h with 
increasing concentrations of paraquat (0.003–1 mM). In detail, culture medium was 
replaced with incubation medium, which consisted of DMEM containing 1% (v/v) 
FBS and the required concentration of paraquat. At the end of the incubation period, 
cellular viability and cell death were determined as described below. From these data, 
a concentration of 1 mM paraquat was chosen, as this produced a submaximal, but 
significant, reduction in cellular viability (approximately 90% reduction in 
mitochondrial respiration compared to untreated controls) and a significant increase in 
cell death (approximately 80% of the lactate dehydrogenase released by cells treated 
with Triton X-100). 
Effects of Mn(II) and Cu(II) complexes of EGTA and EHPG on paraquat-
induced toxicity in NRK-52E cells 
To investigate the effects of the metal complexes of EGTA and EHPG on cellular 
injury and death caused by paraquat, confluent NRK-52E cells were preincubated 
(30 min at 37°C) with 900 μl DMEM containing 1% (v/v) FBS and increasing 
concentrations of Mn(II)-EGTA, Cu(II)-EGTA, Mn(II)-EHPG, or Cu(II)-EHPG (0.3–
100 μM). After 30 min, 100 μl of a 10 mM stock solution of paraquat or its vehicle 
(DMEM containing 1% (v/v) FBS) was added to each well to provide a final 
concentration of paraquat of 1 mM. The concentration range of the complexes used 
was based on those of similar metal-based SODm which have been shown to provide 
protection of rat proximal cells against oxidative stress [31] and [32]. It was also 
assumed, based on previous investigations [25] and on the dosing profile of previous 
experiments using SODm and renal cells [31] and [32], that the complexes would 
remain stable throughout the incubation period. In subsequent experiments, the effects 
of the individual components of the metal complexes of EGTA and EHPG on 
paraquat cytotoxicity were investigated. Specifically, NRK-52E cells were 
preincubated with 900 μl of increasing concentrations of EGTA, EHPG, Mn(II), or 
Cu(II) (0.3–100 μM) prepared in DMEM containing 1% (v/v) FBS, after which 100 μl 
of 10 mM paraquat or its vehicle (DMEM containing 1% (v/v) FBS) was added to 
each well. Cells were then incubated for 24 h after which cellular viability and cell 
death were assessed as described below. 
Measurement of cellular viability (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay) 
Cellular viability or injury was determined as described previously via measurement 
of the mitochondrial-dependent conversion of MTT into a formazan [31], 
[32] and [33]. Results were calculated as the percentage of the absorbance measured 
in control (untreated) cells not exposed to paraquat, which was taken as 100% 
viability and expressed as cellular viability (% untreated control). 
Measurement of cytotoxicity (lactate dehydrogenase (LDH) assay) 
Cell death was determined by measurement of LDH released into the incubation 
medium due to the loss of membrane integrity as described previously [31], 
[32] and [34]. Results were calculated as percentage of the total LDH released from 
control cells (i.e., those not exposed to paraquat) which were incubated with 1% (w/v) 
Triton X-100 (TX-100) for 30 min and expressed as LDH release (% TX-100 
control). 
Effects of Mn(II) and Cu(II) complexes of EGTA and EHPG on paraquat uptake 
by NRK-52E cells 
In order to investigate whether Mn(II) and Cu(II) complexes of EGTA and EHPG 
could alter the uptake of paraquat into NRK-52E cells, the accumulation of 
radiolabeled paraquat was assessed as described previously [35]. Briefly, confluent 
cultures of NRK-52E cells were co-incubated with [methyl-14C]paraquat (0.01 mM) 
and cimetidine (1 mM), tetraethylammonium (TEA) (1 mM), or 100 μM Mn(II)-
EGTA, Cu(II)-EGTA, Mn(II)-EHPG, or Cu(II)-EHPG, prepared in DMEM 
containing 1% (v/v) FBS, for 60 min. The incubation time was based on previously 
published data in which the uptake of paraquat was shown to plateau after 1 h [35]. 
The concentrations of cimetidine and TEA used (1 mM) were based on those shown 
to significantly inhibit the uptake of paraquat into a renal cell line (LLC-PK1) [36]. 
Concentrations of Mn(II) and Cu(II) complexes of EGTA and EHPG were based on 
those providing significant reduction of paraquat toxicity based on the data obtained 
from biochemical assays measuring cellular viability and cell death. Similarly, the 
concentration of paraquat used in these experiments (0.01 mM) was based on that 
previously shown to have no toxic effect on confluent NRK-52E cells. The uptake of 
[methyl-14C]paraquat was expressed as disintegrations per minute per microgram of 
protein and the results were expressed as percentage of control (i.e., based on cells 
treated with paraquat only). 
Effects of preincubation with Mn(II) complexes of EGTA and EHPG on 
paraquat-induced toxicity in NRK-52E cells 
In a separate set of experiments, the ability of Mn(II)-EGTA and Mn(II)-EHPG to 
enter and remain within NRK-52E cells was examined in order to investigate whether 
the Mn(II) complexes were present within cells during the incubation period with 
paraquat. Confluent cultures of NRK-52E cells were incubated with incubation 
medium only or with 100 μM Mn(II)-EGTA or Mn(II)-EHPG. After 20 h incubation, 
for co-incubation studies, incubation medium or paraquat was added to each well to 
provide a final paraquat concentration of 30 mM. For preincubation studies, cells 
were rinsed with warm phosphate-buffered saline (PBS; 0.01 M, pH 7.4) and then 
incubated with either incubation medium or 30 mM paraquat. Earlier studies by the 
authors have shown that incubation of NRK-52E cells with 30 mM paraquat for 4 h 
produces a significant reduction in cell viability and cell death in NRK-52E cells (data 
not shown). After the complete 24-h incubation period, cell viability and death were 
measured using the MTT and LDH assays, respectively. 
Measurement of superoxide anion generation 
The generation of superoxide anion was determined using the widely used nitroblue 
tetrazolium (NBT) assay described previously [37] and [38]. Superoxide anion 
generation was further confirmed by using hydroxyethidium as previously described 
[39]. 
The NBT assay is based on the reduction of NBT by superoxide anion to blue water-
insoluble formazan, which can be monitored spectrophometrically after solubilization 
of the cells. Briefly, NRK-52E cells grown in six-well plates were incubated for 24 h 
with DMEM containing 25 μg/ml NBT in the presence or absence of 1 mM paraquat. 
In addition, NRK-52E cells were co-incubated for 24 h with DMEM with 1% (v/v) 
FBS containing 25 μg/ml NBT and 1 mM paraquat in the presence or absence of SOD 
(EC 1.15.1.1; 1000 U/ml), catalase (EC 1.11.1.6; 1000 U/ml), and protective 
concentrations of Mn(II)-EGTA (100 μM) or Mn(II)-EHPG (100 μM). 
Hydroxyethidium has been shown to be relatively specific for superoxide, which is 
oxidized by superoxide to yield ethidium. Cells were harvested from six-well plates 
previously incubated in DMEM containing 1% (v/v) FBS with 1 mM paraquat in the 
presence or absence of SOD (1000 U/ml), catalase (1000 U/ml), Mn(II)-EGTA 
(100 μM), or Mn(II)-EHPG (100 μM) for 24 h. Cell suspensions were then washed 
with Hanks’ buffered salt solution and then incubated with 10 μM hydroxyethidium 
for 15 min at 37°C. Ethidium fluorescence was then measured using a 
spectrofluorometer set at excitation and emission wavelengths of 473 and 593 nm, 
respectively. 
The concentrations of SOD and catalase were based on previous work by Scheid and 
colleagues in which these antioxidant enzymes were used to protect renal LLC-PK1 
cells against oxidative stress produced by oxalate [38]. Concentrations of Mn(II)-
EGTA and Mn(II)-EHPG were based on concentrations found to provide significant 
protection against paraquat-induced cellular injury and cytotoxicity in earlier 
experiments. Results were expressed as superoxide anion generation (NBT abs. at 
690 nm or ethidium fluorescence % untreated control). 
Measurement of hydroxyl radical generation 
The production of hydroxyl radicals by NRK-52E cells in the absence or presence of 
paraquat was evaluated using the widely used deoxyribose assay, based on the 
principle that the pentose sugar 2-deoxyribose can be cleaved by hydroxyl radicals to 
release a substance that reacts, on heating, with thiobarbituric acid (TBA) to produce 
a pink chromogen [38] and [40]. The chromogen formed in this assay has a spectrum 
which is identical to that of malondialdehyde (MDA) and, therefore, a standard curve 
for MDA is constructed from which the TBA content of samples (which is directly 
proportional to the hydroxyl radicals) can be extrapolated [38]. Briefly, confluent 
NRK-52E cells grown in six-well plates were incubated for 24 h with DMEM 
containing 3 mM deoxyribose in the presence of 1 mM paraquat. In addition, NRK-
52E cells were co-incubated for a predetermined time period with DMEM containing 
3 mM deoxyribose and 1 mM paraquat in the presence of SOD (1000 U/ml), catalase 
(1000 U/ml), or Mn(II)-EGTA or Mn(II)-EHPG (100 μM each). At the end of the 
incubation period, the cell supernatant was removed and assayed for thiobarbiturate 
acid-reactive substances for MDA as previously described [41]. An aliquot of the cell 
supernatant was also used for protein quantification by the Bradford assay [42] and 
the hydroxyl radical content of samples was expressed as MDA formation (nmol/mg 
protein). 
Statistical analysis 
Results are expressed as means ± SEM. Means were obtained from multiple 
experiments performed in triplicate. Data were analyzed and graphed with a 
commercially available software (GraphPad Prism, version 3.0; GraphPad Software, 
San Diego, CA, USA). Differences between mean values within the groups were 
determined using a Student t test or one-way analysis of variance (ANOVA) followed 
by a Dunnett’s test for comparison of multiple means. The level of significance was 
set at p < 0.05. 
 
 
 
Results 
Effects of paraquat on cellular viability and LDH release by NRK-52E cells 
Exposure of confluent NRK-52E cells to paraquat (0.003–1 mM) for 24 h resulted in 
a significant reduction in cellular viability from 100% for control (untreated) cells to 
10% (p <  0.05) for cells incubated with 1 mM paraquat (Fig. 1). As also shown in 
Fig. 1, this was accompanied by a concomitant and significant increase in cell death 
from a baseline value of approximately 20% for control (untreated) cells to 80% 
(p < 0.05) for cells incubated with 1 mM paraquat. 
 
Fig. 1. Effects of paraquat on cellular viability (left) and cell death (right) of NRK-
52E cells. Confluent NRK-52E cells were incubated with increasing concentrations of 
paraquat for 24 h. p < 0.05 vs 0 mM paraquat (untreated control cells treated with 
DMEM only) analyzed using one-way ANOVA followed by Dunnett's posttest, 
N = 10. 
Effects of Mn(II) and Cu(II) complexes of EGTA and EHPG on paraquat 
toxicity 
Incubation of NRK-52E cells with increasing concentrations of Mn(II)-EGTA (0.3–
100 μM) in the presence of 1 mM paraquat produced a significant improvement of 
cellular viability and reduced LDH release compared to cells incubated with 1 mM 
paraquat only (Fig. 2A). Specifically, concentrations of Mn(II)-EGTA greater than 
10 μM increased cellular viability and reduced LDH release significantly (p < 0.05, 
Fig. 2A). 
 Fig. 2. Effects of (A) Mn(II) and (B) Cu(II) complexes of EGTA on viability (left) 
and death (right) of NRK-52E cells. Cultures were incubated with increasing 
concentrations of Mn(II)-EGTA or Cu(II)-EGTA for 24 h in the presence of 1 mM 
paraquat. p < 0.05 vs 0 μM Mn(II)-EGTA or Cu(II)-EGTA + 1 mM paraquat 
analyzed using one-way ANOVA followed by Dunnett's posttest, N = 10. 
Incubation with increasing concentrations of Mn(II)-EGTA only (0.3–100 μM) 
produced a modest but significant reduction in cellular viability from 100 (untreated 
cells) to approximately 90% (p < 0.05); however, similar concentrations of Mn(II)-
EGTA had no effect on baseline LDH release (p > 0.05) (data not shown). 
In contrast, incubation of cells with Cu(II)-EGTA did not have any effect on the 
reduction in cell viability produced by 1 mM paraquat (p > 0.05, Fig. 2B). However, 
the highest concentration of Cu(II)-EGTA produced a modest but significant 
reduction in LDH release caused by 1 mM paraquat (p < 0.05, Fig. 2B). As for 
Mn(II)-EGTA, Cu(II)-EGTA itself produced a modest yet significant reduction in 
cellular viability from 100 (untreated cells) to approximately 87% at a concentration 
range of 1–100 μM (p < 0.05). However, and again in common with Mn(II)-EGTA, 
Cu(II)-EGTA had no effect on baseline LDH release (p > 0.05) (data not shown). 
Mn(II)-EHPG produced a significant improvement in cellular viability at 
concentrations greater than 10 μM (p < 0.05, Fig. 3A). A similar effect was observed 
when the effects of Mn(II)-EHPG on paraquat renal cytotoxicity were assessed, with 
30 and 100 μM Mn(II)-EHPG significantly reducing LDH release caused by 1 mM 
paraquat (p < 0.05, Fig. 3A). Mn(II)-EHPG alone did not have any effect on cellular 
viability or LDH release at the concentration range investigated (0.3–100 μM) 
(p > 0.05) (data not shown). 
 
Fig. 3. Effects of (A) Mn(II) and (B) Cu(II) complexes of EHPG on viability (left) 
and death (right) of NRK-52E cells. Cultures were incubated with increasing 
concentrations of Mn(II)-EHPG or Cu(II)-EHPG for 24 h in the presence 1 mM 
paraquat. p < 0.05 vs 0 μM Mn(II)-EHPG or Cu(II)-EHPG + 1 mM paraquat 
analyzed using one-way ANOVA followed by Dunnett's posttest, N = 10. 
Compared to the reduction in cellular viability produced by paraquat, Cu(II)-EHPG 
significantly reduced cellular viability further at the concentration range 0.3–30 μM 
(p < 0.05, Fig. 3B). However, at the highest concentration examined (100 μM), 
Cu(II)-EHPG increased cellular viability from 9 (paraquat only) to 14% (p < 0.05, 
Fig. 3B) and reduced paraquat-mediated LDH release significantly from 74 (paraquat 
only) to 56% (100 μM Cu(II)-EHPG) (p < 0.05, Fig. 3B). In contrast to its effects on 
cellular viability, lower concentrations of Cu(II)-EHPG (0.3–30 μM) had no effect on 
paraquat-mediated LDH release (Fig. 3B). At the concentrations examined (0.3–
100 μM), Cu(II)-EHPG alone had no effect on cellular viability or LDH release 
(p > 0.05) (data not shown). 
Comparison of the effects of Mn(II) and Cu(II) complexes of EGTA and EHPG 
and their individual components on paraquat-induced renal cell injury and 
cytotoxicity 
As shown in Fig. 4A, incubation of NRK-52E cells with 1 mM paraquat for 24 h 
caused a significant reduction in cellular viability, from 100 (untreated cells) to 7% 
(paraquat only) (p < 0.05, Fig. 4A). Mn(II)-EHPG, at 100 μM, afforded the greatest 
protection against paraquat, increasing cellular viability from 7 (paraquat only) to 
44% (Mn(II)-EHPG) (p < 0.05, Fig. 4A) compared to 100 μM Mn(II)-EGTA and 
100 μM Mn(II), which increased cellular viability to 28 and 24%, respectively. 
Cu(II)-EHPG, at 100 μM, also provided protection against the reduction in cellular 
viability produced by paraquat, increasing it from 7 (paraquat only) to 14% (Cu(II)-
EHPG) (p < 0.05, Fig. 4A); however, this was similar to that provided by 100 μM 
EHPG alone (11%). As shown in Fig. 4A, Cu(II)-EGTA had no effect on paraquat-
induced reduction in cell viability (6%), whereas Cu(II) and EGTA alone actually 
reduced cell viability further (to approximately 2%, p < 0.05). 
 Fig. 4. Summary of the effects of Mn(II) and Cu(II) complexes on (A) cellular 
viability and (B) cell death in the presence of paraquat (PQ). NRK-52E cells were 
incubated with 100 μM Mn(II)-EGTA, Mn(II)-EHPG, Cu(II)-EGTA, or Cu(II)-EHPG 
or their individual components (100 μM) in the presence of paraquat for 24 h. 
p < 0.05 vs untreated cells (DMEM only); + p < 0.05 vs 1 mM PQ only; #p < 0.05 vs 
Mn(II)-EGTA + PQ; ·p < 0.05 vs Cu(II)-EHPG + PQ, analyzed using one-way 
ANOVA followed by Dunnett's posttest, N = 10. 
A similar profile was observed when the effects on the cell death (LDH release) 
caused by paraquat were assessed (Fig. 4B). Incubation with 1 mM paraquat produced 
a significant increase in LDH release from 24 (untreated cells) to 76% (paraquat only) 
(p < 0.05, Fig. 4B). Mn(II)-EHPG, at 100 μM, afforded the greatest protection against 
paraquat, reducing LDH release from 76 (paraquat only) to 31% (Mn(II)-EHPG) 
(p < 0.05, Fig. 4B). This was a significantly greater protection than that afforded by 
100 μM Mn(II)-EGTA. Cu(II)-EHPG and EHPG, at 100 μM, reduced LDH release to 
56 and 72%, respectively (p < 0.05, Fig. 4B). Cu(II)-EHPG, at 100 μM, also provided 
protection against paraquat-mediated LDH release, reducing it from 76 (paraquat 
only) to 56% (Cu(II)-EHPG) (p < 0.05, Fig. 4B). In contrast, Cu(II) increased 
paraquat-mediated LDH release significantly from 76 (paraquat only) to 80% (Cu(II) 
only) (p < 0.05, Fig. 4B). 
It should be noted that in the case of the most protective complex examined, i.e., 
Mn(II)-EHPG, a synergistic degree of protection was obtained when the protection 
provided by the complex was compared to the additive protection provided by its 
components, Mn(II) and EHPG, when examined individually. This synergistic activity 
was apparent in the data obtained from measurement of both cellular viability (Fig. 
4A) and LDH release (Fig. 4B). 
Effects of cimetidine, TEA, and Mn(II) and Cu(II) complexes of EGTA and 
EHPG on uptake of paraquat into NRK-52E cells 
The uptake of [methyl-14C]paraquat (0.01 mM) into confluent NRK-52E cells was not 
inhibited by TEA or the Mn(II) and Cu(II) complexes of either EGTA or EHPG, but 
was significantly inhibited by cimetidine (Fig. 5). Specifically, co-incubation of 
confluent NRK-52E cells for 60 min with 0.01 mM [methyl-14C]paraquat and 1 mM 
cimetidine resulted in a significant reduction in the uptake of paraquat by 
approximately 40% (p < 0.05, Fig. 5). 
 
Fig. 5. Effects of cimetidine, TEA, and Mn(II) and Cu(II) complexes of EGTA and 
EHPG on the uptake of paraquat (PQ) by NRK-52E cells. Confluent NRK-52E cells 
were co-incubated with 0.01 mM PQ and cimetidine (1 mM), TEA (1 mM), or 
Mn(II)-EGTA, Cu(II)-EGTA, Mn(II)-EHPG, or Cu(II)-EHPG (100 μM each) for 
60 min. p < 0.05 vs control (cells treated with PQ only), N = 6. 
Effects of preincubation with Mn(II) complexes of EGTA and EHPG on 
paraquat-induced toxicity in NRK-52E cells 
In order to investigate to what degree the most protective SODm were able to enter 
and remain within NRK-52E cells, confluent cultures were preincubated with 100 μM 
Mn(II)-EGTA or Mn(II)-EHPG followed by a co-incubation with 30 mM paraquat for 
4 h or were incubated with 30 mM paraquat only for 4 h. Incubation with 30 mM 
paraquat for 4 h caused a significant reduction in cell viability (Fig. 6A) and a 
significant increase in cell death (Fig. 6B). However, if the cells were preincubated 
with 100 μM Mn(II)-EGTA or Mn(II)-EHPG for 20 h, followed by co-incubation 
with 30 mM paraquat for 4 h, cellular viability increased significantly from 
approximately 60 to 80% (p < 0.05, Fig. 6A). A similar profile of protection was 
observed for cell death, with co-incubation of the SODm with paraquat reducing cell 
death from approximately 80 to between 40 and 50% (p < 0.05, Fig. 6B). 
Furthermore, if NRK-52E cells were preincubated with 100 μM Mn(II)-EGTA or 
Mn(II)-EHPG for 20 h and then rinsed with warm PBS followed by an incubation 
with 30 mM paraquat only for 4 h, a similar degree of significant protection against 
paraquat toxicity was obtained in terms of both cellular viability (Fig. 6A) and cell 
death (Fig. 6B). 
 
Fig. 6. Effects of preincubation with Mn(II)-EGTA and Mn(II)-EHPG on (A) viability 
and (B) death of NRK-52E cells incubated with paraquat (PQ). Cultures were 
incubated with incubation medium only or incubation medium containing 100 μM 
Mn(II)-EGTA or Mn(II)-EHPG. After 20 h, paraquat was added to the incubation 
medium to a final concentration of 30 mM or cells were rinsed and incubated with 
30 mM paraquat for 4 h. p < 0.05 vs 100 μM Mn(II)-EGTA or Mn(II)-EHPG, 
#p < 0.05 vs 30 mM paraquat only analyzed using one-way ANOVA followed by 
Dunnett's posttest, N = 6. 
 
Effects of Mn(II) and Cu(II) complexes of EGTA and EHPG on the generation of 
reactive oxygen species by paraquat 
As shown in Figs. 7A and B, incubation of NRK-52E cells with 1 mM paraquat for 
24 h produced a significant increase in superoxide anion generation, by 52 and 35% 
as measured by NBT reduction and ethidium fluorescence, respectively (p < 0.05). 
Paraquat-mediated superoxide anion generation was significantly reduced by 
1000 U/ml SOD (p < 0.05), but not by 1000 U/ml catalase (Figs. 7A, B). Mn(II)-
EGTA (100 μM) and Mn(II)-EHPG (100 μM) both reduced superoxide generation by 
paraquat significantly (p < 0.05, Figs. 7A and B). It should be noted that the 
reductions were not significantly different from the reduction in paraquat-induced 
superoxide anion generation obtained using SOD (Figs. 7A and B). 
 Fig. 7. Effects of Mn(II)-EGTA, Mn(II)-EHPG, and antioxidant enzymes on (A and 
B) superoxide anion generation and (C) hydroxyl radical production by NRK-52E 
cells. Cultures were incubated with 1 mM paraquat (PQ) in the presence of 1000 U/ml 
SOD, 1000 U/ml catalase (CAT), 100 μM Mn(II)-EGTA, or 100 μM Mn(II)-EHPG. 
p < 0.05 vs untreated cells (DMEM only); + p < 0.05 vs 1 mM PQ only; #p < 0.05 vs 
SOD + PQ; ·p < 0.05 vs CAT + PQ analyzed using one-way ANOVA followed by 
Dunnett's posttest, N = 8. 
Incubation of cultures with 1 mM paraquat for 24 h also produced a significant 10-
fold increase in hydroxyl radical production (p < 0.05, Fig. 7C). In contrast to 
superoxide generation, 1000 U/ml SOD did not have any effect on hydroxyl radical 
generation; however, 1000 U/ml catalase reduced paraquat-induced generation of 
hydroxyl radical significantly by approximately 68% (p < 0.05, Fig. 7C). Co-
incubation of NRK-52E cells with 1 mM paraquat and 100 μM of either Mn(II)-
EGTA or Mn(II)-EHPG reduced paraquat-induced hydroxyl radical generation from 
3.02 (paraquat only) to 1.91 and 1.69 nmol/mg protein, respectively (p < 0.05, Fig. 
7C). These values were still significantly higher than the reduction in hydroxyl radical 
generation obtained using catalase (p < 0.05, Fig. 7C). 
Discussion 
The results obtained in this investigation clearly demonstrate (i) the renal toxicity of 
paraquat, specifically, a concentration-dependent reduction of cellular viability and 
concomitant increase in cell death, and (ii) the generation of ROS by NRK-52E cells 
exposed to paraquat, specifically, production of significant quantities of superoxide 
anions and hydroxyl radicals. The data presented also demonstrate (i) significant 
protection against paraquat renal cytotoxicity by Mn(II) and Cu(II) complexes of 
EGTA and EHPG, with Mn(II) complexes displaying higher potency and Mn(II)-
EHPG providing the greatest protection, and (ii) the ability of Mn(II)-EGTA and 
Mn(II)-EHPG to reduce the generation of both superoxide anions and hydroxyl 
radical. The protection provided by these complexes against paraquat-induced 
cytotoxicity was obtained at concentrations which were found to be nontoxic to NRK-
52E cells. Finally, protective concentrations of Mn(II) and Cu(II) complexes of 
EGTA and EHPG have been shown not to interfere with the uptake of paraquat into 
NRK-52E cells. 
Superoxide anion generation, and the cellular damage resulting from it, is implicated 
in the pathophysiology of many conditions, including stroke, ischemia, asthma, 
atherosclerosis, and several neurodegenerative diseases [43], [44] and [45]. Increased 
superoxide anion generation due to paraquat and its contribution to paraquat toxicity 
have been catalogued over many years [8], [9], [46] and [47], and in this 
investigation, its role in the development of renal cytotoxicity has been confirmed in 
vitro. The role of superoxide in paraquat toxicity has prompted much interest in the 
development of safe and effective antioxidants to negate its injurious effects [12]. 
Unfortunately, native SOD cannot be used effectively due to recognized problems 
with its short half-life, poor bioavailability, and immunogenicity [13], [14] and [15]. 
Furthermore, SOD can have pro-oxidant activities at higher concentrations, e.g., 
Cu/ZnSOD can promote the generation of hydroxyl radicals [16] and [48] and inhibit 
the ability of superoxide to regulate lipid peroxidation [19] and [49]. This has 
generated much interest in SODm, leading to the development of agents including 
macrocyclics, manganese salens, nitroxides, porphyrins, and many other catalytic 
antioxidants [15], [20], [50], [51], [52], [53], [54] and [55]. However, many of these 
have also suffered problems ranging from cytotoxicity to poor stability [23] and [56]. 
Furthermore, in common with native SOD, higher concentrations of some SODm can 
have pro-oxidant actions [17], [18] and [19]. 
The recent observation that complexes formed between metal ions and the common 
chelator sodium edentate or ethylenediaminetetraacetic acid (EDTA) possess 
significant SODm and catalase mimetic properties [57] prompted the investigation of 
the SOD and catalase activities of other commonly used chelators and their metal 
complexes. Low concentrations of the calcium ion chelator EGTA have been shown 
to solubilize amyloid plaques in postmortem brain samples from patients suffering 
from Alzheimer disease and to reduce nitric oxide (NO)-induced calcium influx into 
endothelial cells and prevent consequent cell death [26] and [27]. Some of these 
beneficial effects of EGTA have been credited to its ability to bind the excess Cu(II) 
ions which contribute to disease pathology; however, it is now also clear that 
complexing EGTA with Cu(II) or Mn(II) promotes significant SOD activity [25]. 
Recently, the related chelating agent EHPG, which is used as a contrast agent for 
magnetic resonance imaging and as a transferrin mimic in the study of manganese 
transport [28] and [29], has also been shown to exhibit significant SOD activity when 
complexed with Mn(II) or Cu(II) [25]. However, the ability of these complexes to 
reduce paraquat toxicity, in which superoxide generation plays a major part, is not 
known and formed the basis of this study. 
In this investigation, Mn(II) and Cu(II) complexes of EGTA and EHPG provided 
significant protection against paraquat cytotoxicity in renal cells, which, in the case of 
Mn(II)-EHPG, was greater than any protection afforded by the individual 
components. Mn(II) complexes of EGTA and EHPG provided greater protection than 
the Cu(II) complexes. The protection afforded by these metal complexes seemed to be 
related to their SODm activity as suggested by their ability to reduce superoxide 
generation by paraquat to a degree similar to that obtained using SOD and support the 
findings of Fisher et al. [25], who demonstrated the SODm activities of Mn(II) and 
Cu(II) complexes of EGTA and EHPG. The order of protection observed against 
paraquat renal cytotoxicity was Mn(II)-EHPG > Mn(II)-EGTA >  Cu(II)-EHPG 
> Cu(II)-EGTA. This profile closely reflected the SOD activities of these complexes 
reported by Fisher and colleagues (Mn(II)-EGTA, 981 U/mg; Mn(II)-EHPG, 
879 U/mg; Cu(II)-EHPG, 409 U/mg; and Cu(II)-EGTA, 314 U/mg), by whom 
measurements were made as units activity per milligram compared to bovine 
erythrocyte SOD, which itself had an activity of 3730 U/mg [25]. These activities 
were higher than the activity of Cu(II)-EDTA at 261 U/mg [57] and considerably 
higher than the activities of Fe(III) complexes of EGTA and EHPG, which were 
measured as 8.76 and 0 U/mg, respectively [25]. In this investigation, EGTA-based 
complexes displayed greater potency than EHPG-based complexes as they reduced 
paraquat-mediated renal cytotoxicity significantly at a concentration of 10 μM; 
however, the highest degree of protection was obtained using Mn(II)-EHPG at 
100 μM. 
Also of interest was the observation that both Mn(II)-EGTA and Mn(II)-EHPG 
reduced hydroxyl radical generation significantly, as determined using the TBA 
reduction assay. Although this was not to the same degree as catalase, it suggests that 
these Mn(II) complexes may also possess some degree of catalase activity or are able 
to scavenge hydroxyl radicals; however, further studies are warranted to confirm this. 
Based solely on the findings of this investigation, it seems that the SODm activity of 
these complexes predominates. 
Paraquat exists as a divalent cation in aqueous solution and is predominantly 
transported into renal proximal tubular cells via a polyvalent organic cation 
transporter (OCT) protein. This uptake of paraquat is saturable with time and with 
increasing concentration of paraquat. It is also energy-dependent and is inhibited by 
certain polyvalent cations, such as quinine, cimetidine, and methylglyoxal 
bis(guanylhydrazine) dihydrochloride [36], [58] and [59]. The inhibitory effect of 
cimetidine, a divalent ion, on the uptake of paraquat into NRK-52E cells as has been 
shown in this study indicates the presence of a polyvalent OCT protein on NRK-52E 
cells and that this OCT is used by paraquat to enter NRK-52E cells. In contrast, TEA, 
a monovalent ion, did not alter paraquat uptake into NRK-52E cells. The observation 
that at protective concentrations, the Mn(II) and Cu(II) complexes of EGTA and 
EHPG did not alter the uptake of paraquat by NRK-52E cells suggests that their 
beneficial effects were not due to a chelating effect or prevention of paraquat uptake, 
e.g., via competition for the OCT for cellular uptake. The lack of effect of the Mn(II) 
and Cu(II) complexes of EGTA and EHPG on paraquat uptake into NRK-52E cells 
also supports the notion that their protection is mediated via intracellular mechanisms, 
i.e., due to their SODm activity subsequent to superoxide generation by paraquat 
within NRK-52E cells. 
The Mn(II) and Cu(II) complexes of EGTA and EHPG seemed to maintain their 
stability in the incubation medium over the 24-h incubation period. As discussed 
above, the complexes did not alter the entry of paraquat into cells, which accumulates 
in renal cells to toxic concentrations over a 24-h period. Protection provided by these 
complexes was observed after 24 h, with the Mn(II) and Cu(II) complexes providing 
greater protection than their individual components, suggesting that the complexes 
maintained their structures. In the case of the most protective agent, Mn(II)-EHPG, 
the complex provided a synergistic level of protection compared to any protection 
afforded by the individual components Mn(II) and EHPG. Furthermore, the results of 
the preincubation study suggest that both Mn(II)-EGTA and Mn(II)-EHPG can enter 
and remain within NRK-52E cells over a 24-h period. Specifically, after 20 h 
incubation with Mn(II)-EGTA or Mn(II)-EHPG, NRK-52E cells were still protected 
against a high concentration of paraquat, even after the cells were rinsed with warm 
PBS. This suggests that these SODm can enter and remain within cells where they 
provide protection against ROS generated by paraquat. However, further studies, e.g., 
using high-pressure/performance liquid chromatography, are warranted to investigate 
whether the SODm remain in an intact state within intact cells or to what degree they 
may dissociate into their components within cells, which may still provide some 
degree of protection, e.g., via the individual actions of Mn and EGTA or EHPG. 
In this particular study, Mn(II) and Cu(II) complexes of EGTA and EHPG did not 
display any pro-oxidant activities at higher concentrations tested. Although Mn(II)-
EGTA, Cu(II)-EGTA, EGTA, EHPG, Mn(II), and Cu(II) produced a modest yet 
significant reduction in cellular viability on their own at higher concentrations, and 
Cu(II)-EHPG, EGTA, and Cu(II) reduced paraquat-mediated reduction in viability 
even further, none of these effects on cellular viability were reflected by LDH release. 
This could suggest that these compounds were causing some degree of mitochondrial 
dysfunction without subsequent cell death; however, it is much more likely that that 
they were interfering directly with the MTT assay. It should be noted here that these 
complexes were examined at relatively low concentrations (maximum 100 μM) and at 
concentrations which were protective against paraquat-induced cytotoxicity; these 
agents did not produce cytotoxicity themselves. Although it would be interesting to 
investigate higher concentrations of these complexes to see if greater protection or 
increasing toxicity could be observed and to compare these with protective and toxic 
concentrations of other SODm such as MnTBAP, EUK-8, and M40401, 
concentrations greater than 100 μM were not tested due to problems of solubility of 
these complexes in the incubation medium. However, the relatively safe profile of 
Mn(II) and Cu(II) complexes of EGTA and EHPG should allow investigations of 
these complexes in vivo to assess their efficacy against many pathological conditions 
involving ROS generation and oxidative stress. Specifically, these complexes could 
be investigated in models of ischemic or nephrotoxic ARF, which involve significant 
ROS generation and in which other SODm have been shown to provide beneficial 
effects [31], [32] and [51]. However, although there was no evidence of Cu(II) 
toxicity in this study, some care may need to be taken when Cu(II) complexes are 
utilized in view of a report that Cu(II) derived from Cu/ZnSOD may facilitate 
oxidative stress in the presence of glutathione [17]. Both EGTA and EHPG have the 
advantage that they have already been used in biological systems for their chelation 
and imaging properties and therefore their clinical toxicity profiles are already known. 
Furthermore, SOD and catalase activities of Mn(II), Cu(II), and Fe(III) complexes of 
another chelating agent, EDTA, have previously been reported [57] and subsequently, 
EDTA itself has been reported to protect against ischemic renal injury via modulation 
of endothelial NO synthase and NO production [60]. It is hoped that, based on the 
findings of this investigation, Mn(II) and Cu(II) complexes of EGTA and EHPG may 
provide similar benefits. 
In conclusion, the novel SODm, Mn(II) and Cu(II) complexes of EGTA and EHPG 
reduced paraquat renal cytotoxicity significantly via reduction of paraquat-mediated 
ROS generation, specifically superoxide anions. Mn(II) complexes were generally 
more potent than the Cu(II) complexes, with the complex Mn(II)-EHPG providing the 
highest degree of protection. Unlike conventional SODm, which can display pro-
oxidant actions at higher concentrations, these complexes at the highest concentration 
examined were not toxic to the renal NRK-52E cells utilized in this study. These 
results therefore demonstrate that these novel SODm have the potential to be used for 
the treatment of paraquat-induced nephrotoxicity and, possibly, for many other 
pathological conditions involving oxidative stress. 
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